Brief: Astrazeneca Pharma India June-Quarter PAT Falls
09/08/2021 09:45
Aug 9 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* JUNE-QUARTER PAT 102.4 MILLION RUPEES VERSUS PROFIT 186.3
MILLION RUPEES YEAR AGO
* JUNE-QUARTER REVENUE FROM OPERATIONS 1.75 BILLION RUPEES
VERSUS
1.94 BILLION RUPEES YEAR AGO
* DECLARED INTERIM DIVIDEND OF 2 RUPEES/SHARE
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication